Literature DB >> 7911047

Interleukin 13 elicits a subset of the activities of its close relative interleukin 4.

G Zurawski1, J E de Vries.   

Abstract

Interleukin 13 (IL-13) and interleukin 4 (IL-4) are two closely related proteins produced by activated T cells. IL-4 is a well characterized mediator of various aspects of the immune response, including anti-inflammatory effects on monocytes and macrophages, regulation of B cell function, T cell growth, and regulation of adhesion molecule expression on endothelial cells. IL-13, a more recently characterized cytokine, appears to exhibit IL-4-like activities on monocytes, macrophages and human B cells, but has no effect on T cells. While there is a close parallel between IL-4 activities on human and mouse cells, IL-13 activities in these two systems appear to differ substantially with a notable absence of effect on mouse B cells. This review briefly summarizes the current state of knowledge of the interrelated activities of IL-13 and IL-4, explores the basis of these effects at the receptor level and attempts to rationalize the existence of these close relatives via differences in their production by T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911047     DOI: 10.1002/stem.5530120204

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  14 in total

1.  IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain.

Authors:  R L Palmer-Crocker; C C Hughes; J S Pober
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  Molecular aspects of regulation of collagen gene expression in fibrosis.

Authors:  Rashpal K Bhogal; Cristina M Stoica; Tracy L McGaha; Constantin A Bona
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

3.  Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery.

Authors:  Seunguk Oh; John R Ohlfest; Deborah A Todhunter; Vincent D Vallera; Walter A Hall; Hua Chen; Daniel A Vallera
Journal:  J Neurooncol       Date:  2009-06-11       Impact factor: 4.130

Review 4.  Interleukin-13: prospects for new treatments.

Authors:  C E Brightling; S Saha; F Hollins
Journal:  Clin Exp Allergy       Date:  2009-10-30       Impact factor: 5.018

5.  Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression.

Authors:  J Wang; G Roderiquez; T Oravecz; M A Norcross
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain.

Authors:  Thirumalai R Ramalingam; John T Pesce; Faruk Sheikh; Allen W Cheever; Margaret M Mentink-Kane; Mark S Wilson; Sean Stevens; David M Valenzuela; Andrew J Murphy; George D Yancopoulos; Joseph F Urban; Raymond P Donnelly; Thomas A Wynn
Journal:  Nat Immunol       Date:  2007-12-09       Impact factor: 25.606

7.  Identification of interleukin genes in Pogona vitticeps using a de novo transcriptome assembly from RNA-seq data.

Authors:  Alexandra Livernois; Kristine Hardy; Renae Domaschenz; Alexie Papanicolaou; Arthur Georges; Stephen D Sarre; Sudha Rao; Tariq Ezaz; Janine E Deakin
Journal:  Immunogenetics       Date:  2016-06-02       Impact factor: 2.846

8.  Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma.

Authors:  Akiva Mintz; Denise M Gibo; A B Madhankumar; Waldemar Debinski
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

9.  IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.

Authors:  Akiva Mintz; Denise M Gibo; Becky Slagle-Webb; Neil D Christensen; Waldemar Debinski
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

10.  Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice.

Authors:  Douglas A Jabs; Robert A Prendergast; Adam L Campbell; Bella Lee; Esen Karamursel Akpek; Hervé C Gérard; Alan P Hudson; Judith A Whittum-Hudson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-12       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.